本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1994/10/141 分钟阅读
National Institute of Mental Health; Licensing Opportunity and/or Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Use of Retroviral Vectors With Gibbon Ape Leukemia Virus (GaLV) Components
本地自动翻译 · 来源原始语言
摘要
The National Institutes of Health is seeking licensees and/or CRADA partners for the further development, evaluation, and commercialization of novel retroviral vectors with Gibbon Ape Leukemia Virus (GaLV) components. The invention claimed in the following patent application is available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under a CRADA for important clinical and research applications as described below in the Supplementary Information:
来源原始语言: Federal Register — Health and Human Services打开原始公告 →